Choosing Route of Consumption
Dr. Sarah Mann, an intensive care doctor, explores the various modes of administration for cannabis medicine and the pros and cons of each.
Dr. Sarah Mann, an intensive care doctor, explores the various modes of administration for cannabis medicine and the pros and cons of each.
The Society of Cannabis Clinicians, along with various organizations, sent a letter to the United Nations urging representatives to ease access to medical cannabis for patients across the world during the COVID-19 pandemic.
The Society of Cannabis Clinicians (SCC) is seeking interns to support the organization in various ways. These internships will provide an opportunity to work with a society of experts and deepen skills and experience in the cannabis field. Learn more.
Dawn-Marie Steentra, LPN guides us through a day in the life of a Cannabis Nurse. The work requires ongoing compassion, education, and enthusiasm for patient advocacy.
Dr. Kevin M.Takakuwa details the history of the SCC, which is the first and oldest U.S. medical organization promoting the use of medical cannabis.
Bobby Eisenberg has worked with El Dorado officials to develop regulations that recognize a patient’s right to grow as much cannabis as their doctor authorizes. Now the planning commission in El Dorado Country wants to impose a six-plant limit.
What would we envision as the best cannabis model for international patient access? This question was explored at a collaborative event in Barcelona just before the COVID-19 lockdowns swept over Spain (and the world).
Joe D. Goldstrich, MD, FACC outlines what we know about the antiviral properties of cannabis and whether or not it could be helpful or detrimental for COVID-19.
Sarah Mann, MD separates myth and conjecture from what is known (and unknown) about cannabis and sex.
This review paper by Dr. Robert Silver gives an overview of the ECS in animals and highlights it as a topic of interest for emerging therapeutics.
Does cannabis have synergy with other plants? James Brent, DDS reviews the literature.
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).